VAIA
XLRN

Virtus Alternative Investment Advisers’s Acceleron Pharma XLRN Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-51
Closed -$7K – 268
2020
Q4 		$7K Sell
51
-50
-50% -$5.86K 0.1% 168
2020
Q3 		$11K Sell
101
-32
-24% -$3.19K 0.2% 248
2020
Q2 		$13K Sell
133
-124
-48% -$12K 0.2% 223
2020
Q1 		$23K Buy
257
+52
+25% +$4.04K 0.32% 86
2019
Q4 		$11K Buy
+205
New +$9.35K 0.17% 17

Other funds holding XLRN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Virtus Alternative Investment Advisers's XLRN Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Acceleron Pharma (XLRN) in Q1 2021, closing a stake of 51 shares — an estimated $7K sold.

Virtus Alternative Investment Advisers first reported a position in XLRN in Q4 2019 and held it in 5 quarters. The position peaked at $23K in Q1 2020. 256 funds tracked by Wall St. Rank hold XLRN as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Acceleron Pharma position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 51 Acceleron Pharma shares in Q1 2021, an estimated $7K.
  • Virtus Alternative Investment Advisers first reported a position in Acceleron Pharma in Q4 2019 and held it in 5 quarters.
  • Virtus Alternative Investment Advisers's Acceleron Pharma position peaked at $23K in Q1 2020.
  • 256 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.